• A functional single-nucleotide polymorphism in the catechol-O-methyltransferase gene alter vitiligo risk in a Chinese population
• A novel de novo TSC2 nonsense mutation detected in a pediatric patient with tuberous sclerosis complex
• A novel TSC1 mutation (c.1964delA) in a Chinese patient with tuberous sclerosis complex
• A novel TSC2 missense variant associated with a variable phenotype of tuberous sclerosis complex: case report of a Chinese family
• A Rare Presentation of Attention Deficit/Hyperactivity Disorder: A recommendation to be more alert!
• A subtle case of tuberous sclerosis complex
• Amelanotic/Hypomelanotic melanoma--is dermatoscopy useful for diagnosis?
• Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo
• Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China
• Angiofibromas with multiple epidermoid cysts in tuberous sclerosis: new mutation or post-traumatic?
• Arachnoid cysts in tuberous sclerosis complex
• Association of Clinical Markers With Disease Progression in Patients With Vitiligo From China
• Association of hypomelanotic skin disorders with autism: links to possible etiologic role of vitamin-D levels in autism?
• Association of multiple retinal nodular hamartomas and "confetti" skin lesions with end-stage renal disease in patients with tuberous sclerosis
• Associations of hypomelanotic skin disorders with autism: Do they reflect the effects of genetic mutations and epigenetic factors on vitamin-D metabolism in individuals at risk for autism?
• Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo
• Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo
• Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library
• Beyond polycystic kidney disease
• BRAF and KIT somatic mutations are present in amelanotic melanoma
• Cardiac Rhabdomyoma: A Surrogate Diagnosis of Tuberous Sclerosis Complex in a Newborn Baby: Case Report from Tikur Anbessa University Hospital
• Characterisation of the paediatric population of Costa Rica with tuberous sclerosis and a description of the behaviour of the associated epilepsy
• Childhood autism in a 13 year old boy with oculocutaneous albinism: a case report
• Clinical and genetic study patients with tuberous sclerosis complex
• Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex
• Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo
• Clinical markers of vitiligo activity
• Clinical practice guidelines for the diagnosis and management of melanoma: melanomas that lack classical clinical features
• Clinical presentation and diagnosis of tuberous sclerosis complex in infancy
• Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival
• Coexistence of tuberous sclerosis complex and malignant melanoma
• Conjunctival lymphangioma in a 4-year-old girl revealed tuberous sclerosis complex
• Corrigendum to "Development of hypomelanotic macules is associated with constitutive activated mTORC1 in tuberous sclerosis complex" [Mol. Genet. Metab. 120(4) (Apr 2017) 384-391]
• Cutaneous Manifestations of Tuberous Sclerosis
• De novo mutation of the TSC2 gene in patient with Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND) Phenotype: a case report
• Dendritic cells and their associated pro-inflammatory cytokines augment to the inflammatory milieu in vitiligo skin
• Dermatological manifestations of tuberous sclerosis complex (TSC)
• Dermoscopic evaluation of nodular melanoma
• Development of hypomelanotic macules is associated with constitutive activated mTORC1 in tuberous sclerosis complex
• Diagnosis of tuberous sclerosis complex
• Do you know this syndrome?
• Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?
• Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo
• Erythrocyte malondialdehyde and glutathione levels in vitiligo patients
• ESPED-Survey: TSC-disease in children and adolescents: preliminary results from a German epidemiological survey
• Filippi syndrome: Three new families suggest that urinary system abnormalities may belong to clinical spectrum of the disease
• Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States
• Giant cell angiofibroma of gingiva in tuberous sclerosis complex: a case report and literature review
• Histological Patterns of Skin Lesions in Tuberous Sclerosis Complex: A Panorama
• Hypomelanotic melanoma detected by the "little red riding hood sign" in a patient with neurofibromatosis type 1
• Hypomelanotic melanoma mimicking pigmented Bowen disease
• Hypomelanotic melanoma simulating pigmented Bowen's disease and its challenging dermoscopic features
• Identification of a de novo TSC2 variant in a Han-Chinese family with tuberous sclerosis complex
• In-situ immune profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis
• Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study
• Juvenile xanthogranuloma as a new type of skin lesions in tuberous sclerosis complex
• Key point in dermoscopic differentiation between early nail apparatus melanoma and benign longitudinal melanonychia
• Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients
• Mucocutaneous changes in tuberous sclerosis complex: a clinical profile of 27 Indian patients
• Muenke syndrome with pigmentary disorder and probable hemimegalencephaly: An expansion of the phenotype
• Nevus Depigmentosus: An Update
• No association between catalase (CAT) gene polymorphisms and susceptibility to vitiligo in a Turkish population
• Noncultured Epidermal Suspension in Vitiligo-A Review of Origins, Modifications, and Innovations for this Surgical Masterstroke!
• Oral and neurocutaneous phenotypes of familial tuberous sclerosis
• Origin, clinical presentation, and diagnosis of hypomelanotic skin disorders
• Patients' and physicians' awareness of clinical symptoms and disease severity in tuberous sclerosis complex
• Phakomatoses
• Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients
• Pimecrolimus for idiopathic guttate hypomelanosis
• Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases
• Premature graying of hair
• Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants
• Primary melanoma of the urinary tract; Clinicopathologic and molecular review of a case series
• Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics
• Review of the spectrum of tuberous sclerosis complex: The Saudi Arabian Experience
• Serum Inflammatory and Oxidative Stress Markers in Patients with Vitiligo
• Severity in phenotypic expression of homozygous sickle cell disease (Hb.SS)--does hypermelanotic or hypomelanotic skin status of affected patients play a role?
• SIRT1 regulates MAPK pathways in vitiligo skin: insight into the molecular pathways of cell survival
• Study of oxidative stress in vitiligo
• The great mimicker: Phenotypic overlap between constitutional mismatch repair deficiency and Tuberous Sclerosis complex
• The Immunogenetics of Vitiligo: An Approach Toward Revealing the Secret of Depigmentation
• Topical Use of Mammalian Target of Rapamycin (mTOR) Inhibitors in Tuberous Sclerosis Complex-A Comprehensive Review of the Literature
• Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients
• TSC2/PKD1 contiguous deletion syndrome in a pregnant woman: A case report
• Tuberous Sclerosis
• Tuberous Sclerosis Complex
• Tuberous sclerosis complex
• Tuberous Sclerosis Complex in 29 Children: Clinical and Genetic Analysis and Facial Angiofibroma Responses to Topical Sirolimus
• Tuberous Sclerosis Complex in Chinese patients: Phenotypic analysis and mutational screening of TSC1/TSC2 genes
• Tuberous sclerosis complex misdiagnosed as multiple metastases in a cervical cancer patient: case report and literature review
• Tuberous sclerosis complex presenting as primary intestinal lymphangiectasia: A case report
• Tuberous sclerosis complex: A clinical diagnosis in Ethiopian patients
• Tuberous Sclerosis Complex: Early Screening and Infant Outcome in NICU
• TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients
• Tuberous sclerosis: a rare cause of seizure in Nigeria
• Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin
• Ungual fibroma in 12-year-old boy with hypomelanotic macules, intellectual disability and attention deficit hyperactivity disorder-possible tuberous sclerosis
• Unusual radiological presentation of tuberous sclerosis complex with leptomeningeal angiomatosis associated with a hypomorphic mutation in the TSC2 gene
• Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation
• Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: a case report